Jasper Therapeutics, Inc.: files amendment to correct Item 9.01 exhibits

What happened This Current Report on Form 8-K/A ("Amendment No. 2") filed Oct 5, 2026, amends Item 9.01 (Financial statements and exhibits). The filing states that .01(a) and .01(b) of Form 8-K were not included in the Original Form 8-K and that Amendment No. 1 inadvertently included an incomplete version of Exhibit 99.3. Amendment No. 2 replaces or supplements those omitted or incomplete exhibits.

Key details

• Filing date: Oct 5, 2026; Accession number: 0001213900-26-106574.
• Item amended: Item 9.01 (Financial statements and exhibits).
• Missing items: .01(a) and .01(b) of the Original Form 8-K were omitted.
• Correction: Amendment No. 1 included an incomplete Exhibit 99.3; Amendment No. 2 addresses that error.

Why it may matter The filing reports an amendment to Item 9.01, which covers financial statements and exhibits that should be attached to a Form 8-K. A filing does not show why the insider traded or why the company acted.